Seeking Alpha

Array BioPharma (ARRY +2.4%) trades up after announcing positive results from Phase 1 and 2...

Array BioPharma (ARRY +2.4%) trades up after announcing positive results from Phase 1 and 2 testing of its kinesin spindle protein inhibitor, ARRY-520, yesterday at the annual meeting of the American Society of Hematology in San Diego, California.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs